As I suspected, I would not know what you are talking about.
Where is the 1st or 2nd $4.6m in cash? And where's the $10m you talk about?
Your response seems to be exactly what we get from management, being not a single decent answer to any substantive question.
Did John give these (non) answers to you?
Here's the thing Syd, most of the posters here can READ and have read what you so beautifully cut and pasted into the post. Many posters here can also ask questions and reasonably expect answers, despite their lack of forthcoming.
You said "Singapore alone already provides the opportunity for NSP to grow 10 baggers to move into ASX 300."
We were told in 2006 that Gels were going to be the 10 bagger, then it was SpermSep in 2007 (which is still being promised), then BioEnquire in 2009 (BTW which resulted in an $8m loss last year!), then Singapharm in 2010, which morphed into PRIME which had a Philippine LOI which has seemed to evaporate with no news.
Along the way, every year, at the AGM we're told about being an ASX300 company. A few more shares are issued to the board and a few of their mates and the price goes down as does the market cap.
This trend has been the case since back in the days of Gradipore, where these same guys were in charge and destroyed value as they promised that we'd be an ASX300 company.
If you have any doubt about the destruction of value for NuSep holders, there's still info available at NuSepBoardReform.info. If you invested at the start of NuSep you've lost 99.2%. For those investor, these guys need a 128 bagger to break even.
I have tried to be upbeat about this, and while the announcements have always seemed great, the lack of info and the lack of buying by the board, with no explanation, makes me suspect it is more of the same.....spin to get more money from us shareholders. I'll bet you a steak lunch, there'll be a hand out to shareholders (or at least some shareholders) before the year is out! I'll see you at Kingsleys (I assume you are in Sydney) on the 1st January.
MEM Price at posting:
7.3¢ Sentiment: None Disclosure: Held
